scholarly journals Disturbo da binge-eating - Un update

IJEDO ◽  
2020 ◽  
pp. 29-40
Author(s):  
Riccardo Dalle Grave ◽  
Simona Calugi ◽  
Massimiliano Sartirana
Keyword(s):  
Weight Loss ◽  
Binge Eating ◽  
Impulse Control ◽  
Depressive Disorders ◽  
Normal Weight ◽  
Behaviour Therapy ◽  
Compensatory Behaviors ◽  
Cognitive Behaviour ◽  
Clinically Significant ◽  
New Treatment

Binge-eating disorder (BED) is characterized by the presence of recurrent binge-eating episodes not followed by the recurrent use of compensatory behaviors, occurring at least once a week for three months, and associated with marked distress. According to the most recent data, BED has a lifetime prevalence of 0.85% (men 0.42% and women 1.25%). The disorder, although it is also present in normal-weight individuals, is more frequent in those with obesity. BED often coexists with specific mental disorders (e.g., depressive disorders, anxiety disorders, substance use disorders, or impulse control disorders) and with general medical conditions (e.g., cardiometabolic diseases). Psychological treatments, such as cognitive behaviour therapy (CBT), produce remission of binge-eating episodes in about 50-55% of patients, but have a limited effect on weight loss when BED is associated with obesity. Pharmacological treatments for anxiety and depression have limited effects on the symptoms of BED, while some drugs that have shown promising results, such as lisdexamfetamine and dasotraline, are often burdened with important side effects and are not available in Italy. The need to develop a treatment able to determine both a modest, but clinically significant, weight loss and a simultaneous remission of binge-eating episodes and associated psychopathology, has led to design a new treatment, under evaluation, called “CBT-BO”, which integrates strategies and procedures of the CBT-E for eating disorders and CBT for obesity.

scholarly journals The Real Happy Study: Protocol for a Prospective Assessment of the Real-World Effectiveness of the HAPIFED Program—a Healthy APproach to weIght management and Food in Eating Disorders

2019 ◽  
Vol 9 (7) ◽  
pp. 72 ◽  
Author(s):  
Andrea L. Pattinson ◽  
Natasha Nassar ◽  
Felipe Q. da Luz ◽  
Phillipa Hay ◽  
Stephen Touyz ◽  
...  
Keyword(s):  
Eating Disorders ◽  
Weight Loss ◽  
Binge Eating ◽  
Real World ◽  
Eating Behaviour ◽  
Excess Body Weight ◽  
Physical And Mental Health ◽  
Behaviour Therapy ◽  
The Real ◽  
Cognitive Behaviour

The prevalence of obesity with comorbid binge eating behaviour is growing at a faster rate than that seen for either obesity or eating disorders as separate conditions. Approximately 6% of the population are affected and they potentially face a lifetime of poor physical and mental health outcomes and an inability to sustain long-term weight loss. Current treatment options are inadequate in that they typically address either obesity or eating disorders exclusively, not the combination of both conditions. By treating one condition without treating the other, relapse is common, and patients are often left disappointed with their lack of weight loss. An integrated approach to treating these individuals is needed to prevent a worsening of the comorbidities associated with excess body weight and eating disorders. A new therapy has recently been developed, named HAPIFED, which addresses both overweight/obesity and comorbid binge eating behaviour with the combination of behavioural weight loss therapy and cognitive behaviour therapy-enhanced (CBT-E). The aim of this paper is to document the protocol for the Real Happy Study, which will evaluate the effectiveness of the HAPIFED program in treating overweight or obesity with comorbid binge-eating behaviour in a real-world setting.

Fluoxetine and Fluvoxamine Combined with Individual Cognitive-Behaviour Therapy in Binge Eating Disorder: A One-Year Follow-Up Study

2001 ◽  
Vol 70 (6) ◽  
pp. 298-306 ◽  
Author(s):  
Valdo Ricca ◽  
Edoardo Mannucci ◽  
Barbara Mezzani ◽  
Sandra Moretti ◽  
Milena Di Bernardo ◽  
...  
Keyword(s):  
Eating Disorder ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Cognitive Behaviour Therapy ◽  
Behaviour Therapy ◽  
Follow Up Study ◽  
Cognitive Behaviour ◽  
One Year

Predictors of Outcome for Cognitive Behaviour Therapy in Binge Eating Disorder

2015 ◽  
Vol 23 (3) ◽  
pp. 219-228 ◽  
Author(s):  
Mirjam W. Lammers ◽  
Maartje S. Vroling ◽  
Machteld A. Ouwens ◽  
Rutger C. M. E. Engels ◽  
Tatjana van Strien
Keyword(s):  
Eating Disorder ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Cognitive Behaviour Therapy ◽  
Predictors Of Outcome ◽  
Behaviour Therapy ◽  
Cognitive Behaviour

Mental illness as a predictor of patient attendance and anthropometric changes: observations from an Australian publicly funded obesity management service

2020 ◽  
pp. 103985622095371
Author(s):  
Louise Brightman ◽  
Alexandra Dunne ◽  
Hsin-Chia Carol Huang
Keyword(s):  
Mental Illness ◽  
Weight Loss ◽  
Depressive Disorders ◽  
Psychotic Disorders ◽  
Management Service ◽  
Obesity Management ◽  
Significant Weight Loss ◽  
Retrospective Audit ◽  
Schizophrenia Spectrum ◽  
Clinically Significant

Objective: Obesity is associated with co-morbid mental illness. The Canberra Obesity Management Service (OMS) supports adults with severe obesity who have the psychosocial capacity to engage. This study will determine whether mental illness is a predictor of OMS attendance and anthropometric changes. Method: A retrospective audit was performed from July 2016 to June 2017. Baseline characteristics, attendance and anthropometrics were stratified according to the presence of mental illness. Outcomes included weight stabilisation and clinically significant weight loss. Descriptive analyses were performed. Results: Mental illness was present in 60/162 patients (37%). Attendance was similar for those with and without mental illness. Patients with mental illness had twice as many co-morbidities ( p = .001). Depressive disorders were most common ( n = 28, 47%). Anxiety, schizophrenia spectrum and other psychotic disorders, and trauma- and stressor-related disorders also featured. Weight stabilisation was achieved by 25 patients (66%) with mental illness and 25 (35%) without. Clinically significant weight loss was observed in 10 patients (26%) with and 26 (40%) without mental illness. Conclusion: The presence of mental illness did not impact OMS attendance or weight stabilisation. The higher rate of co-morbidities in those with mental illness highlights the challenges faced by this vulnerable population.

THE TREATMENT OF WHEELCHAIR-BOUND CHRONIC FATIGUE SYNDROME PATIENTS: TWO CASE STUDIES OF A PRAGMATIC REHABILITATION APPROACH

1999 ◽  
Vol 27 (3) ◽  
pp. 249-260 ◽  
Author(s):  
Pauline Powell ◽  
Richard H. T. Edwards ◽  
Richard P. Bentall
Keyword(s):  
Chronic Fatigue Syndrome ◽  
Case Studies ◽  
Chronic Fatigue ◽  
Behaviour Therapy ◽  
Face To Face ◽  
Fatigue Syndrome ◽  
End Of Treatment ◽  
Cognitive Behaviour ◽  
Ambulatory Patients ◽  
Clinically Significant

Chronic fatigue syndrome is a disabling condition characterized by persistent mental and physical fatigue. Its aetiology is controversial, and it has been attributed to both physical and psychological causes. Previous controlled trials with ambulatory patients have shown that a proportion of CFS patients respond to cognitive-behaviour therapy. In this paper, we report two case studies of patients who are wheelchair-bound, who have been treated by a pragmatic intervention designed to increase activity and challenge dysfunctional illness beliefs. The patients received 60 and 55 contacts with the therapist, some of which were face-to-face and some of which were by telephone. At the end of treatment, the patients experienced clinically significant reductions in fatigue, were not using wheelchairs, showed an increase in occupational and social functioning and were leading relatively independent existences.

BATTLING BOREDOM: GROUP COGNITIVE BEHAVIOUR THERAPY FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA

2002 ◽  
Vol 30 (3) ◽  
pp. 341-346 ◽  
Author(s):  
Louise C. Johns ◽  
William Sellwood ◽  
John McGovern ◽  
Gillian Haddock
Keyword(s):  
Group Intervention ◽  
Negative Symptoms ◽  
Control Design ◽  
Inclusion Criteria ◽  
Behaviour Therapy ◽  
Cognitive Behavioural ◽  
Cognitive Behaviour ◽  
The Subject ◽  
Clinically Significant ◽  
Group Cbt

We conducted a pilot group intervention for negative symptoms, particularly targeting avolition/apathy. A baseline control design was used. Six patients were recruited, and four completed the group. The main inclusion criteria were clinically significant negative symptoms, plus associated distress and concern. The group involved 16 sessions, which were cognitive behavioural in approach. The main outcome measures were the Scale for the Assessment of Negative Symptoms, and the Subject Experience of Negative Symptoms Scale. Patients showed a reduction in avolition/apathy, and two patients reported reduced distress. These preliminary results suggest that group CBT is a possible intervention for negative symptoms.

CBT-based App for Women Experiencing Chronic Pelvic Pain: A Pilot Study (Preprint)

2020 ◽  
Author(s):  
Arthur Stabolidis ◽  
Christina Bryant ◽  
Greg Wadley ◽  
Lisa Phillips
Keyword(s):  
Pilot Study ◽  
Pelvic Pain ◽  
Participatory Design ◽  
Chronic Pelvic Pain ◽  
Randomised Control Trial ◽  
Behaviour Therapy ◽  
Post Intervention ◽  
Cognitive Behaviour ◽  
The Mean ◽  
Clinically Significant

BACKGROUND Chronic Pelvic Pain (CPP) is a costly and distressing condition and while psychological interventions are effective, they are often not utilised or available. Cost, stigma and lack of time are often presented as reasons for why some women with CPP do not engage with these therapies. Increasingly, technology-mediated therapies have been adopted in the management of long-term health conditions to help overcome barriers commonly associated with face-to-face interventions. OBJECTIVE The objective of the study was to design and pilot a technology-based intervention for women experiencing CPP. We employed a user-centered approach involving women with CPP and clinicians in the co-design process. METHODS To co-design the intervention we conducted five participatory design workshops at a public hospital for women. The data gathered informed the design of an app-based intervention called appEase. We pilot tested appEase with women (N = 16) who were asked to use the app daily over 28 days. Data collected during the pilot included a series of baseline, mid- and post-intervention measures, and usage data collected from within the app. RESULTS Workshop findings suggested that a smartphone application, appEase, that delivers a course in mindfulness, pain education and Cognitive Behaviour Therapy (CBT) was consistent with the goals and needs of this patient group. Pilot testing indicated that although appEase was designed to be used for a period of 28 days, the mean completion time for the intervention was 64 days. Ten participants (63%) experienced clinically significant reductions in Pain Catastrophising (PC), and nine (56%) experienced clinically significant increases in Pain Self-Efficacy (PSE). When asked how confident they would be in recommending the program to a person with chronic pain, the mean rating was 8.44 (out of 10). CONCLUSIONS Psychological therapy embodied in a smartphone app shows promise for women experiencing CPP. This study highlights the importance of co-design and provides a useful exemplar for designers of technology-mediated health programs for women experiencing CPP. Furthermore, it has produced a sound empirical basis for testing the efficacy of appEase in a randomised control trial. CLINICALTRIAL Not registered as it is a pilot study with no funding from national agencies

Cognitive behaviour therapy for depressive disorders

2012 ◽  
pp. 1304-1313 ◽  
Author(s):  
Melanie J. V. Fennell
Keyword(s):  
Mental Illness ◽  
Personality Disorder ◽  
Severe Mental Illness ◽  
Effective Treatment ◽  
Psychiatric Disorders ◽  
Cognitive Behaviour Therapy ◽  
Depressive Disorders ◽  
Behaviour Therapy ◽  
Cognitive Behavioural ◽  
Cognitive Behaviour

This chapter describes A.T. Beck's cognitive behaviour therapy (CBT) for depression. Beck's is probably the most fully developed, comprehensively evaluated, and widely disseminated cognitive behavioural approach to depression. Additionally, CBT is an effective treatment for a range of acute psychiatric disorders, shows promise for severe mental illness and personality disorder, and is thus helpful not only with primary depression, but also with a range of comorbid conditions.

Sign in / Sign up

Export Citation Format

Share Document